Sol-Millennium® Celebrates Positive Feedback on Needle-Free Insulin Injection Device in Canada
Sol-Millennium® Celebrates Positive Feedback on Needle-Free Insulin Injection Device in Canada
Hear from InsuJet Needle-Free device users like Paige Grant. Diagnosed with Type 1.5 diabetes a few years ago, Paige opens up about her journey. Initially feeling overwhelmed and hesitant about managing her condition, she avoided proper medication and doubted her ability to take on challenging activities like hiking. Since adopting the InsuJet device, Paige has not only transformed her approach to self-care but also regained the confidence to push her limits and embrace new adventures.
CHICAGO--(BUSINESS WIRE)--Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection device for insulin administration, receiving widespread praise in Canada. Designed to improve the lives of millions of people with diabetes, this breakthrough technology eliminates the discomfort and anxiety often associated with traditional needle-based injections.
The device, InsuJet™, employs advanced jet injection technology to deliver precise doses of insulin without the need for needles. It aims to make insulin administration more comfortable and reduces injection-related stress.
Early reviews from Canadian users highlight its success. Lilly, a teenager from Alberta, shared her experience: "I’ve always used needles for insulin, but the InsuJet has been a game-changer. It helps my body absorb insulin faster, reducing high blood sugar spikes. Plus, it doesn’t leave bruises or marks on my skin, which I love."
Key Features of InsuJet™:
- Needle-Free Technology: Delivers insulin via a high-pressure stream, ensuring a comfortable experience.
- Precision and Safety: Eliminates needle-related injuries and sharps disposal concerns.
- Portability: Perfect for managing diabetes on the go.
- Eco-Friendly: Reduces household waste by eliminating the need for sharps containers.
Grayden, a user from Ontario, emphasized the device's convenience and cost-effectiveness: "Switching to InsuJet was an easy decision. The cost of needles was becoming a burden, and this device is so much simpler to set up. It’s also much less wasteful compared to traditional pen tips."
Similarly, Paige Grant, diagnosed with Type 1.5 diabetes, shared her transformation:
"At first, I was overwhelmed by my diagnosis and avoided proper medication. But since using the InsuJet, I’ve regained my confidence, embraced self-care, and even taken on new adventures like hiking."
As InsuJet™ becomes available across Canadian pharmacies, its impact on diabetes care continues to grow, offering improved quality of life for countless individuals.
For more information about InsuJet™, please visit www.solm.com/insujet/.
About Sol-Millennium® Medical Group
Sol-Millennium® Medical Group is one of the world's largest manufacturers of needles and syringes. It is vertically integrated with locations across the globe. Sol-Millennium's innovative technology supports positive patient outcomes, saves on medication, and enhances both clinician and patient experience. With an international sales team dedicated to delivering knowledge and outstanding customer service, Sol-Millennium’s goal is to partner with those in healthcare, focusing on a healthier tomorrow.
For more information about Sol-Millennium® and other innovative health solutions, please visit www.solm.com.
Contacts
